Tracey L. McCain

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tracey L. McCain:

Company Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp EVP & Chief Legal Officer Stock Option (Right to Buy) 0 $793,100 $36.05 17 Jul 2025 Direct
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Share 12,546 $321,177 $25.60 05 Jun 2025 Direct
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Share 9,373 $167,589 $17.88 06 Jun 2024 Direct
Blueprint Medicines Corp EVP & Chief Legal Officer Common Stock 0 $0 $128.18 17 Jul 2025 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Stock Option (right to buy) 0 $0 $4.56 12 Feb 2024 Direct
Kiniksa Pharmaceuticals International, plc Director Share Option 16,798 03 Jun 2025 Direct
Kiniksa Pharmaceuticals International, plc Director Restricted Share Units 0 05 Jun 2025 Direct
Kiniksa Pharmaceuticals, Ltd. Director Restricted Share Units 0 06 Jun 2024 Direct

Insider Reports Filed by Tracey L. McCain

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BPMC Blueprint Medicines Corp 17 Jul 2025 13 $0 4 EVP & Chief Legal Officer 21 Jul 2025, 19:45
KNSA Kiniksa Pharmaceuticals International, plc 03 Jun 2025 4 $0 4 Director 05 Jun 2025, 16:59
BPMC Blueprint Medicines Corp 05 Mar 2025 1 -$467,266 4 EVP AND CHIEF LEGAL OFFICER 07 Mar 2025, 16:12
BPMC Blueprint Medicines Corp 01 Mar 2025 2 $0 4 EVP AND CHIEF LEGAL OFFICER 04 Mar 2025, 17:20
KNSA Kiniksa Pharmaceuticals, Ltd. 05 Jun 2024 4 $0 4 Director 07 Jun 2024, 16:37
BPMC Blueprint Medicines Corp 07 Mar 2024 1 -$471,044 4 EVP AND CHIEF LEGAL OFFICER 11 Mar 2024, 18:18
BPMC Blueprint Medicines Corp 01 Mar 2024 2 $0 4 EVP AND CHIEF LEGAL OFFICER 06 Mar 2024, 16:25
/report/000110465924014702-mccain-tracey-l-2024-02-12 ImmunoGen, Inc. 12 Feb 2024 5 $0 4 Director 12 Feb 2024, 16:39
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:15
/report/000141588923009952-mccain-tracey-l-2023-06-14 ImmunoGen, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:49
KNSA Kiniksa Pharmaceuticals, Ltd. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:19
BPMC Blueprint Medicines Corp 06 Mar 2023 2 -$151,743 4 EVP AND CHIEF LEGAL OFFICER 08 Mar 2023, 20:27
BPMC Blueprint Medicines Corp 01 Mar 2023 2 $0 4 EVP AND CHIEF LEGAL OFFICER 03 Mar 2023, 19:02
/report/000141588923000301-mccain-tracey-l-2022-12-30 ImmunoGen, Inc. 30 Dec 2022 1 $0 4 Director 04 Jan 2023, 15:19
/report/000141588922010222-mccain-tracey-l-2022-09-30 ImmunoGen, Inc. 30 Sep 2022 1 $0 4 Director 04 Oct 2022, 16:15
/report/000141588922007342-mccain-tracey-l-2022-06-30 ImmunoGen, Inc. 30 Jun 2022 1 $0 4 Director 05 Jul 2022, 16:34
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2022 2 $0 4 Director 30 Jun 2022, 16:21
/report/000141588922006699-mccain-tracey-l-2022-06-15 ImmunoGen, Inc. 15 Jun 2022 2 +$86,124 4 Director 17 Jun 2022, 16:07
/report/000117911022002537-mccain-tracey-l-2022-03-31 ImmunoGen, Inc. 31 Mar 2022 1 $0 4 Director 04 Apr 2022, 16:13
BPMC Blueprint Medicines Corp 03 Mar 2022 2 -$159,318 4 EVP AND CHIEF LEGAL OFFICER 08 Mar 2022, 15:05
BPMC Blueprint Medicines Corp 01 Mar 2022 2 $0 4 EVP AND CHIEF LEGAL OFFICER 03 Mar 2022, 19:02
BPMC Blueprint Medicines Corp 07 Dec 2021 5 -$344,690 4 EVP and Chief Legal Officer 09 Dec 2021, 15:01
/report/000117911021010213-mccain-tracey-l-2021-11-15 ImmunoGen, Inc. 15 Nov 2021 2 +$249,920 4 Director 17 Nov 2021, 15:10
/report/000117911021010210-mccain-tracey-l-2021-11-15 ImmunoGen, Inc. 15 Nov 2021 0 $0 3 Director 17 Nov 2021, 15:08
BPMC Blueprint Medicines Corp 03 Nov 2021 4 -$411,012 4 EVP and Chief Legal Officer 05 Nov 2021, 16:01
BPMC Blueprint Medicines Corp 23 Sep 2021 5 -$2,012,349 4 EVP and Chief Legal Officer 27 Sep 2021, 16:30
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2021 1 $0 4 Director 30 Jun 2021, 16:22